BBP holdings

All 63 positions of Virtus Biotech ETF.

Download CSV

Positions

Top 10 weight

25.5%

Effective holdings

53.5

1 / sum of squared weights

In stocks

99.5%

In bonds

0.0%

Outside the US

18.3%

Asset mix

Equity99.5%
Cash3.2%

Sectors

93% of stocks classified

Health Care92.5%

Countries

United States81.2%
Cayman Islands5.1%
United Kingdom3.3%
Switzerland3.0%
Bermuda2.1%
Germany1.7%
Denmark1.7%
Canada1.5%

Holdings

#	Holding	Type	Weight	Value	Shares / par	Country
1	IBRXImmunityBio, Inc. Common Stock	Equity	4.80%	$2.8M	401,005	US
2	DREYFUS GOVERNMENT CASH MANAGE	Cash	3.15%	$1.9M	1,868,134	US
3	APLSApellis Pharmaceuticals, Inc. Common Stock	Equity	2.59%	$1.5M	37,509	US
4	KALVKalVista Pharmaceuticals, Inc. Common Stock	Equity	2.52%	$1.5M	55,964	US
5	MRNAModerna, Inc. Common Stock	Equity	2.49%	$1.5M	32,122	US
6	IOVAIovance Biotherapeutics, Inc. Common Stock	Equity	2.44%	$1.4M	430,167	US
7	MIRMMirum Pharmaceuticals, Inc. Common Stock	Equity	2.39%	$1.4M	14,558	US
8	AXSMAxsome Therapeutics, Inc	Equity	2.24%	$1.3M	6,386	US
9	KINIKSA PHARMACEUTICALS INTERNATIONAL PLC	Equity	2.06%	$1.2M	22,754	GB
10	ROIVANT SCIENCES LTD	Equity	2.06%	$1.2M	42,821	BM
11	ZLABZai Lab Limited American Depositary Shares	Equity	1.94%	$1.2M	53,256	KY
12	LGNDLigand Pharmaceuticals Inc.	Equity	1.93%	$1.1M	4,992	US
13	BCRXBioCryst Pharmaceuticals Inc	Equity	1.93%	$1.1M	125,015	US
14	TVTXTravere Therapeutics, Inc. Common Stock	Equity	1.93%	$1.1M	27,170	US
15	NVAXNovavax Inc	Equity	1.93%	$1.1M	144,044	US
16	UTHRUnited Therapeutics Corp	Equity	1.84%	$1.1M	1,914	US
17	GERNGeron Corp	Equity	1.81%	$1.1M	695,861	US
18	BNTXBioNTech SE American Depositary Share	Equity	1.74%	$1.0M	9,981	DE
19	AMGNAmgen Inc	Equity	1.74%	$1.0M	2,977	US
20	EXELExelixis Inc	Equity	1.74%	$1.0M	23,148	US
21	BIIBBiogen Inc. Common Stock	Equity	1.73%	$1.0M	5,434	US
22	GILDGilead Sciences Inc	Equity	1.73%	$1.0M	7,859	US
23	TGTXTG Therapeutics, Inc.	Equity	1.72%	$1.0M	30,187	US
24	KRYSKrystal Biotech, Inc. Common Stock	Equity	1.71%	$1.0M	3,866	US
25	LEGNLegend Biotech Corporation American Depositary Shares	Equity	1.68%	$997K	42,398	KY
26	SNDXSyndax Pharmaceuticals, Inc.	Equity	1.68%	$996K	46,457	US
27	ARWRArrowhead Research Corporation	Equity	1.67%	$992K	13,501	US
28	ASNDAscendis Pharma A/S Ordinary Share	Equity	1.66%	$985K	4,293	DK
29	AGIOAgios Pharmaceuticals, Inc.	Equity	1.64%	$972K	34,703	US
30	HALOHalozyme Therapeutics, Inc.	Equity	1.63%	$968K	15,211	US
31	ARDXArdelyx, Inc.	Equity	1.63%	$965K	152,393	US
32	BMRNBioMarin Pharmaceuticals Inc	Equity	1.61%	$957K	17,750	US
33	INCYIncyte Genomics Inc	Equity	1.59%	$945K	9,918	US
34	AUPHAurinia Pharmaceuticals Inc	Equity	1.55%	$919K	59,707	CA
35	SRPTSarepta Therapeutics,, Inc. Common Stock	Equity	1.55%	$918K	43,955	US
36	REGNRegeneron Pharmaceuticals Inc	Equity	1.52%	$902K	1,276	US
37	BBIOBridgeBio Pharma, Inc. Common Stock	Equity	1.51%	$895K	12,592	US
38	VRTXVertex Pharmaceuticals Inc	Equity	1.51%	$895K	2,093	US
39	ONCBeOne Medicines Ltd. American Depositary Shares	Equity	1.48%	$875K	2,965	CH
40	IONSIonis Pharmaceuticals, Inc. Common Stock	Equity	1.48%	$875K	11,708	US
41	CRISPR THERAPEUTICS AG	Equity	1.47%	$874K	16,695	CH
42	THERAVANCE BIOPHARMA INC	Equity	1.47%	$872K	52,082	KY
43	MDGLMadrigal Pharmaceuticals, Inc. Common Stock	Equity	1.44%	$856K	1,655	US
44	KURAKura Oncology, Inc.	Equity	1.38%	$818K	92,599	US
45	NBIXNeurocrine Biosciences Inc	Equity	1.38%	$815K	6,192	US
46	PTCTPTC Therapeutics, Inc.	Equity	1.37%	$814K	12,510	US
47	ACADAcadia Pharmaceuticals Inc.	Equity	1.32%	$782K	34,855	US
48	ARQTArcutis Biotherapeutics, Inc. Common Stock	Equity	1.28%	$757K	32,610	US
49	TARSTarsus Pharmaceuticals, Inc. Common Stock	Equity	1.25%	$740K	11,632	US
50	ALNYAlnylam Pharmaceuticals, Inc.	Equity	1.24%	$736K	2,379	US
51	HRMYHarmony Biosciences Holdings, Inc. Common Stock	Equity	1.23%	$730K	23,360	US
52	PHATPhathom Pharmaceuticals, Inc. Common Stock	Equity	1.23%	$728K	64,997	US
53	CRNXCrinetics Pharmaceuticals, Inc.	Equity	1.23%	$727K	18,743	US
54	IMCRImmunocore Holdings plc American Depositary Shares	Equity	1.21%	$718K	25,714	GB
55	RYTMRhythm Pharmaceuticals, Inc. Common Stock	Equity	1.14%	$678K	8,333	US
56	INSMInsmed, Inc.	Equity	1.10%	$655K	4,801	US
57	RAREUltragenyx Pharmaceutical Inc.	Equity	1.09%	$645K	26,120	US
58	NUVBNuvation Bio Inc.	Equity	0.84%	$500K	112,261	US
59	ESPREsperion Therapeutics, Inc.	Equity	0.83%	$492K	245,810	US
60	ADMAADMA Biologics, Inc.	Equity	0.83%	$490K	47,844	US
61	LENZLENZ Therapeutics, Inc. Common Stock	Equity	0.79%	$468K	52,170	US
62	OABIWOmniAb, Inc. Warrant	Equity	0.00%	$0	1,295	US
63	OABIWOmniAb, Inc. Warrant	Equity	0.00%	$0	1,295	US

Find which other funds hold a stock by opening it and choosing "ETFs holding".

Position changes between reports

Action	Holding	Weight before	Weight after	Shares vs flows	Between reports
Exit	DVAXDynavax Technologies Corp	2.18%	—	—	Jan 30, 2026 → Apr 30, 2026 SEC
Exit	FOLDAmicus Therapeutics Inc	2.06%	—	—	Jan 30, 2026 → Apr 30, 2026 SEC
Exit	DAWNDay One Biopharmaceuticals Inc	2.03%	—	—	Jan 30, 2026 → Apr 30, 2026 SEC

Share-count changes are measured after removing what creations and redemptions explain.

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.